The Hamilton Eye Institute at UTHSC is currently participating in an observational study trying to understand new onset eye issues (e.g. conjunctivitis) associated with the drug Dupixent. We are looking for your help in referring patients for this study.
Key Points for this study:
Any patients with new onset eye issues after Dupixent treatment are potentially eligible.
• Enrolled patients will be compensated for their time and effort
• Insurance not needed to participate
• All patients will be referred to you for ongoing care
Please contact us for more information and/or to refer a patient; patients can also call us directly.
Contact Information:
Penny Asbell, MD, FACS, MBA at 901-448-1911. Or email: pasbell@uthsc.edu
Andrew Fernandez, MD, Coordinator at 901-448-7375. Or email: aferna22@uthsc.edu
